These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 26700707

  • 1. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
    Eaton BR, Esiashvili N, Kim S, Weyman EA, Thornton LT, Mazewski C, MacDonald T, Ebb D, MacDonald SM, Tarbell NJ, Yock TI.
    Int J Radiat Oncol Biol Phys; 2016 Jan 01; 94(1):133-138. PubMed ID: 26700707
    [Abstract] [Full Text] [Related]

  • 2. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX, Ioakeim-Ioannidou M, Susko MS, Rao AD, Yeap BY, Snijders AM, Ladra MM, Vogel J, Zaslowe-Dude C, Marcus KJ, Yock TI, Grassberger C, Braunstein SE, Haas-Kogan DA, Terezakis SA, MacDonald SM.
    Int J Radiat Oncol Biol Phys; 2021 Mar 01; 109(3):726-735. PubMed ID: 33243479
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR, Dunkel IJ, Souweidane MM, Khakoo Y, Lyden DC, Gilheeney SW, Becher OJ, Budnick AS, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):e15-20. PubMed ID: 21481547
    [Abstract] [Full Text] [Related]

  • 7. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.
    Eaton BR, Esiashvili N, Kim S, Patterson B, Weyman EA, Thornton LT, Mazewski C, MacDonald TJ, Ebb D, MacDonald SM, Tarbell NJ, Yock TI.
    Neuro Oncol; 2016 Jun 01; 18(6):881-7. PubMed ID: 26688075
    [Abstract] [Full Text] [Related]

  • 8. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):782-7. PubMed ID: 17892918
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor bed proton irradiation in young children with localized medulloblastoma.
    Grewal AS, Li Y, Fisher MJ, Minturn J, Paltin I, Belasco J, Phillips P, Kang T, Lustig RA, Hill-Kayser C.
    Pediatr Blood Cancer; 2019 Dec 01; 66(12):e27972. PubMed ID: 31512390
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM, Becker KP, Yu JB, Bindra RS, Roberts KB.
    Neuro Oncol; 2017 Feb 01; 19(2):259-269. PubMed ID: 27540083
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R, Howell RM, Taddei PJ, Giebeler A, Mahajan A, Newhauser WD.
    Radiother Oncol; 2014 Oct 01; 113(1):84-8. PubMed ID: 25128084
    [Abstract] [Full Text] [Related]

  • 16. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
    Fukunaga-Johnson N, Lee JH, Sandler HM, Robertson P, McNeil E, Goldwein JW.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):143-6. PubMed ID: 9747831
    [Abstract] [Full Text] [Related]

  • 17. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS.
    Eur J Cancer; 2005 Mar 01; 41(5):727-34. PubMed ID: 15763649
    [Abstract] [Full Text] [Related]

  • 18. Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.
    Sun LM, Yeh SA, Wang CJ, Huang EY, Chen HC, Hsu HC, Lee SP.
    J Neurooncol; 2002 May 01; 58(1):77-85. PubMed ID: 12160144
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.